2013 American Transplant Congress
Pre-Recovery Liver Biopsy in Brain Death Donors – Case Control Study of Safety, Feasibility and Liver Utilization
Department of Surgery, UMDNJ-NJMS, Newark, NJ
Background: Pre-recovery liver biopsy (PLB) has potential to decrease costs of futile liver recovery and increase recovered utilization, therefore we examined its safety, feasibility, and…2013 American Transplant Congress
Genetic Adaptation of Polyomavirus BK (BKV) to Immunologic and Pharmacologic Selection Pressure
BACKGROUND: Characterizing the genomic plasticity of BKV will further our understanding of viral epidemiology, diagnosis, and clinical outcome, and facilitate development of vaccines and drug…2013 American Transplant Congress
Tauroursodeoxycholic Acid Alleviate Ischemia-Reperfusion Injury in Donation after Cardiac Death Liver Transplantation
Background Donation after Cardiac Death (DCD) liver graft can provide possible and practical solutions to the organ shortage crisis, but extended warm ischemia time aggravates…2013 American Transplant Congress
Presence of Pre-Transplant Donor Specific Antibody (DSA) Does Not Reduce Pancreas Allograft Survival in Recipients Treated with IVIG
Department of Surgery, Multi Organ Transplant Program, Toronto General Hospital, Toronto, ON, Canada
Background: Evidence indicates that pre-transplant donor specific antibody (DSA) in kidney transplantation recipients worsens graft survival significantly. The impact of pre-transplant DSA on pancreas transplant…2013 American Transplant Congress
Pancreas (Px) Transplantation (Tx) Following Donation after Cardiac Death (DCD): 5 Year Outcomes – Matched Pair Analysis
Surgery, University of Minnesota, Minneapolis, MN
DCD Px donors are underutilized accounting for <3% of PxTx in the US. We hypothesize that outcomes of Px Tx from DCD are comparable to…2013 American Transplant Congress
Immunologic Outcomes in Clinical Face Transplantation with Large Volume Vascularized Bone Marrow Component
University of Maryland School of Medicine, Baltimore
Preclinical data generated in our non-human primate (NHP) model of face vascularized composite allografts (VCA) demonstrated immunosuppressive benefit of vascularized bone marrow (VBM) as a…2013 American Transplant Congress
Thymoglobulin Is Safe and Effective as Induction Therapy for Early Steroid Withdrawal in Pediatric Renal Transplantation
Surgery, NewYork-Presbyterian/Weill Cornell Medical Center, New York, NY
Introduction:Early steroid withdrawal (SW) for maintenance immunosuppression has been gaining acceptance in pediatric kidney transplant recipients. Despite its use in adult renal transplants, data on…2013 American Transplant Congress
Belimumab (Anti-BAFF/BLyS) Effective in a Case of Resistant Antibody Mediated Rejection
Division of Nephrology, University of Washington, Seattle, WA
PURPOSE: Belimumab is a humanized IgG1 monoclonal antibody to B-cell activating factor (BAFF), also known as B-lymphocyte Stimulator (BLyS). BAFF works through three receptors to…2013 American Transplant Congress
Early Look at Transplant Outcomes from the OPTN KPD Pilot Program: Comparing Cold Times and DGF Rates with Other Living and Deceased Donor Transplants, An
UNOS; Yale Medical Ctr; Univ of Florida; Northwestern Univ; Carnegie Mellon Univ
Purpose: In Dec 2010, the Organ Procurement and Transplantation Network Kidney Paired Donation Pilot Program (OPTN KPDPP) facilitated the first of 27 (through Nov 2012)…2013 American Transplant Congress
Influence of Carbon Monoxide-Releasing Molecule-3 Treatment on Dendritic Cell Maturation and Infiltration
Carbon monoxide (CO) can provide beneficial anti-inflammatory effects during organ transplantation. In a murine renal allograft model, treatment with Carbon monoxide-releasing molecule-3 (CORM-3) reduces cellular…
American Transplant Congress abstracts